CellPro Inc. announced Wednesday that it has filed with theSecurities and Exchange Commission for an offering of 2.5million shares of common stock (NASDAQ:CPRO).
The company has granted an additional 375,000-shareoverallotment option to the underwriters, managed byPaineWebber Inc., Oppenheimer & Co. Inc. and Punk, Ziegel &Knoell.
CellPro of Seattle has developed a unique and fully integratedsystem that can be used to separate specific cells from complexcell mixtures for use in therapeutic, diagnostic and researchapplications.
CellPro's stock was down $1.75 a share on Wednesday, to$22.13.
(c) 1997 American Health Consultants. All rights reserved.